Back to search
FDAFDA · Food and drugs·Recall number D-0876-2018

Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90

Published June 13, 2018 · Recall initiated: May 25, 2018

Summary

FDA records drug Class III recall D-0876-2018, published June 13, 2018 and initiated May 25, 2018. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 2,328 bottles (Lot VR417065A) and 2,352 bottles (Lot VR417066A); Lot: Lot #: VR417065A, VR417066A, Exp 10/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
IN, MI, MS, NC, NJ, NY and OH
Lot
Lot #: VR417065A, VR417066A, Exp 10/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90 recalled?

Yes. FDA published recall D-0876-2018 on June 13, 2018. Reported hazard: Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).

What should I do if I have this product?

Voluntary: Firm initiated · Letter